Cyclacel Pharmaceuticals, Inc. (CYCC)
NASDAQ: CYCC · IEX Real-Time Price · USD
1.652
+0.012 (0.73%)
Jul 22, 2024, 10:10 AM EDT - Market open
CYCC's stock price has decreased by -85.51% in the past year and price targets may not have had time to catch up.
Cyclacel Pharmaceuticals Analyst Ratings
Total Analysts
2
Consensus Rating
Buy
Price Target
$11.00
Upside
+565.86%
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Roth MKM | Roth MKM | Strong Buy Maintains $21 → $11 | Strong Buy | Maintains | $21 → $11 | +565.86% | May 3, 2024 |
| Brookline Capital | Brookline Capital | Strong Buy → Hold Downgrades n/a | Strong Buy → Hold | Downgrades | n/a | n/a | Dec 19, 2023 |
| Roth MKM | Roth MKM | Strong Buy Maintains $16 → $21 | Strong Buy | Maintains | $16 → $21 | +1,171.19% | Dec 19, 2023 |
| Oppenheimer | Oppenheimer | Buy Maintains $120 | Buy | Maintains | $120 | +7,163.92% | May 25, 2023 |
| Oppenheimer | Oppenheimer | Buy Maintains $150 → $120 | Buy | Maintains | $150 → $120 | +7,163.92% | Mar 7, 2023 |
| Oppenheimer | Oppenheimer | Buy Initiates $255 | Buy | Initiates | $255 | +15,335.84% | Jul 18, 2022 |
| Oppenheimer | Oppenheimer | Buy Initiates $255 | Buy | Initiates | $255 | +15,335.84% | Apr 30, 2021 |